Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7850
+0.0350 (2.00%)
NASDAQ· Last Trade: Jun 1st, 10:07 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors